Focusing on the captured sialoglycans [α2,3- (MAL-II) and α2,6-linked sialic acid (SNA)] populations, CD13 present in breast cancer CDX tissue was observed to present different sialylation, particularly α2,3 sialoglycans, compared to normal tissues. This evidence concerns the gene ANPEP and breast cancer.